TABLE 3.

Median inhibitory and bactericidal titers in serum of gatifloxacin and moxifloxacin over time against aerobic bacteria^a

Organism and time point (h)	Gatifloxacin		Moxifloxacin
	SIT (range)	SBT (range)	SIT (range)	SBT (range)
H. influenzae
2	1:32 (1:32)	1:32 (1:32)	1:32 (1:32)	1:32 (1:32)
6	1:32 (1:32)	1:32 (1:32)	1:32 (1:32)	1:32 (1:16-1:32)
12	1:32 (1:32)	1:32 (1:32)	1:32 (1:16-1:32)	1:32 (1:16-1:32)
24	1:32 (1:16-1:32)	1:16 (1:16-1:32)	1:32 (1:16-1:32)	1:16 (1:8-1:16)
S. pneumoniae
2	1:8 (1:8-1:16)	1:8 (1:4-1:8)	1:16 (1:16-1:32)	1:16 (1:4-1:32)
6	1:8 (1:4-1:8)	1:4 (1:4-1:8)	1:16 (1:8-1:16)	1:8 (1:8-1:16)
12	1:4 (1:2-1:4)	1:2 (<1:2-1:4)	1:8 (1:4-1:16)	1:8 (1:4-1:8)
24	<1:2 (<1:2)	<1:2 (<1:2)	1:4 (1:2-1:4)	1:4 (1:2-1:4)
S. aureus
2	1:32 (1:16-1:32)	1:16 (1:4-1:32)	1:32 (1:32)	1:32 (1:16-1:32)
6	1:16 (1:16-1:32)	1:16 (1:4-1:16)	1:32 (1:32)	1:32 (1:16-1:32)
12	1:16 (1:8-1:16)	1:8 (1:4-1:16)	1:16 (1:16-1:32)	1:16 (1:4-1:32)
24	1:4 (1:2-1:8)	1:2 (<1:2-1:4)	1:8 (1:8-1:16)	1:4 (1:2-1:8)

^aSIT, serum inhibitory titer; SBT, serum bactericidal titer.